TY - JOUR
T1 - Dynamic metabolic engineering of Escherichia coli improves fermentation for the production of pyruvate and its derivatives
AU - Soma, Yuki
AU - Yamaji, Taiki
AU - Hanai, Taizo
N1 - Funding Information:
We thank S. Shota (University of California, Davis) for providing the plasmids pSA126 and pSA150. This work was supported by JSPS KAKENHI Grant Numbers JP23119002 , JP20H02544 , JP18K14065 , Japan Association for Chemical Innovation , and a grant for a Basic Science Research Project from the Sumitomo Foundation .
Publisher Copyright:
© 2021 The Society for Biotechnology, Japan
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Pyruvate is a key intermediate that is involved in various synthetic metabolic pathways for microbial chemical and fuel production. It is widely used in the food, chemical, and pharmaceutical industries. However, the microbial production of pyruvate and its derivatives compete with microbial cell growth, as pyruvate is an important metabolic intermediate that serves as a hub for various endogenous metabolic pathways, including gluconeogenesis, amino acid synthesis, TCA cycle, and fatty acid biosynthesis. To achieve a more efficient bioprocess for the production of pyruvate and its derivatives, it is necessary to reduce the metabolic imbalance between cell growth and target chemical production. For this purpose, we devised a dynamic metabolic engineering strategy within an Escherichia coli model, in which a metabolic toggle switch (MTS) was employed to redirect metabolic flux from the endogenous pathway toward the target synthetic pathway. Through a combination of TCA cycle interruption through MTS and reduction of pyruvate consumption in endogenous pathways, we achieved a drastic improvement (163 mM, 26-fold) in pyruvate production. In addition, we demonstrated the redirection of metabolic flux from excess pyruvate toward isobutanol production. The final isobutanol production titer of the strain harboring MTS was 26% improved compared with that of the control strain.
AB - Pyruvate is a key intermediate that is involved in various synthetic metabolic pathways for microbial chemical and fuel production. It is widely used in the food, chemical, and pharmaceutical industries. However, the microbial production of pyruvate and its derivatives compete with microbial cell growth, as pyruvate is an important metabolic intermediate that serves as a hub for various endogenous metabolic pathways, including gluconeogenesis, amino acid synthesis, TCA cycle, and fatty acid biosynthesis. To achieve a more efficient bioprocess for the production of pyruvate and its derivatives, it is necessary to reduce the metabolic imbalance between cell growth and target chemical production. For this purpose, we devised a dynamic metabolic engineering strategy within an Escherichia coli model, in which a metabolic toggle switch (MTS) was employed to redirect metabolic flux from the endogenous pathway toward the target synthetic pathway. Through a combination of TCA cycle interruption through MTS and reduction of pyruvate consumption in endogenous pathways, we achieved a drastic improvement (163 mM, 26-fold) in pyruvate production. In addition, we demonstrated the redirection of metabolic flux from excess pyruvate toward isobutanol production. The final isobutanol production titer of the strain harboring MTS was 26% improved compared with that of the control strain.
UR - http://www.scopus.com/inward/record.url?scp=85117289725&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117289725&partnerID=8YFLogxK
U2 - 10.1016/j.jbiosc.2021.09.015
DO - 10.1016/j.jbiosc.2021.09.015
M3 - Article
C2 - 34674961
AN - SCOPUS:85117289725
SN - 1389-1723
VL - 133
SP - 56
EP - 63
JO - Journal of Bioscience and Bioengineering
JF - Journal of Bioscience and Bioengineering
IS - 1
ER -